Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boostrix new syringe presentation immunogenicity study in healthy adolescents
2013-003768-30Phase 4
- Sponsor
- GSK
- Start
- Mar 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of acellular pertussis vaccine in diphtheria, Tetanus and pertussis (2 arms), sponsored by GSK. Primary endpoint: Immunogenicity with respect to components of the study vaccine.
02
Drugs
acellular pertussis vaccine
03
Conditions
diphtheriaTetanuspertussis
Beyond the preview
Go deeper on 2013-003768-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003768-30.